National Variations in Recent Trends of Sudden Unexpected Infant Death Rate in Western Europe.

Europe epidemiology infant mortality public health sudden infant death syndrome sudden unexpected death in infancy trends

Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
11 2020
Historique:
received: 24 03 2020
revised: 25 05 2020
accepted: 17 06 2020
pubmed: 26 6 2020
medline: 6 1 2022
entrez: 26 6 2020
Statut: ppublish

Résumé

To study recent epidemiologic trends of sudden unexpected death in infancy (SUDI) in Western Europe. Annual national statistics of death causes for 14 Western European countries from 2005 to 2015 were analyzed. SUDI cases were defined as infants younger than 1 year with the underlying cause of death classified as "sudden infant death syndrome," "unknown/unattended/unspecified cause," or "accidental threats to breathing." Poisson regression models were used to study temporal trends of SUDI rates and source of variation. From 2005 to 2015, SUDI accounted for 15 617 deaths, for an SUDI rate of 34.9 per 100 000 live births. SUDI was the second most common cause of death after the neonatal period (22.2%) except in Belgium, Finland, France, and the UK, where it ranked first. The overall SUDI rate significantly decreased from 40.2 to 29.9 per 100 000, with a significant rate reduction experienced for 6 countries, no significant evolution for 7 countries, and a significant increase for Denmark. The sudden infant death syndrome/SUDI ratio was 56.7%, with a significant decrease from 64.9% to 49.7% during the study period, and ranged from 6.1% in Portugal to 97.8% in Ireland. We observed between-country variations in SUDI and sudden infant death syndrome sex ratios. In studied countries, SUDI decreased during the study period but remained a major cause of infant deaths, with marked between-country variations in rates, trends, and components. Standardization is needed to allow for comparing data to improve the implementation of risk-reduction strategies.

Identifiants

pubmed: 32585240
pii: S0022-3476(20)30755-1
doi: 10.1016/j.jpeds.2020.06.052
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-185.e4

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Sophie de Visme (S)

INSERM CIC1413, Nantes University Hospital, Nantes, France; INSERM UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Centre (CRESS), Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Université de Paris, Paris, France. Electronic address: sophie.de-visme@inserm.fr.

Martin Chalumeau (M)

INSERM UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Centre (CRESS), Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Université de Paris, Paris, France; Department of General Pediatrics and Pediatric Infectious Diseases, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France.

Karine Levieux (K)

Pediatric Emergency Care Unit, Nantes University Hospital, Nantes, France.

Hugues Patural (H)

Pediatric Intensive Care Unit, Saint-Étienne University Hospital, Saint Etienne, France.

Inge Harrewijn (I)

Pediatric Intensive Care Unit, Montpellier University Hospital, Montpellier, France.

Elisabeth Briand-Huchet (E)

Pediatric Intensive Care Unit, Antoine Béclère University Hospital, AP-HP, Clamart, France.

Grégoire Rey (G)

INSERM CépiDc, Epidemiology Center on Medical Causes of Death, Le Kremlin-Bicêtre, France.

Claire Morgand (C)

INSERM UMR 1181, Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Versailles Saint Quentin University, Villejuif, France.

Béatrice Blondel (B)

INSERM UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Centre (CRESS), Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Université de Paris, Paris, France.

Christèle Gras-Le Guen (C)

INSERM CIC1413, Nantes University Hospital, Nantes, France; INSERM UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Centre (CRESS), Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Université de Paris, Paris, France; Pediatric Emergency Care Unit, Nantes University Hospital, Nantes, France.

Matthieu Hanf (M)

INSERM UMR 1181, Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Versailles Saint Quentin University, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH